Skip to main content

Recurrent Neurological Symptoms Mistaken as Multiple Sclerosis

  • Chapter
Stroke Medicine

Abstract

Fabry’s is an X-linked lysosomal storage disease. It can manifest a variable phenotype including cerebrovascular disease in heterozygous females, Diagnosis in female heterozygotes is challenging, as it may mimic atherosclerotic disease and/or small vessel vasculopathy, and alpha-galactosidase levels may be normal. This case of a 47-year-old female with recurrent symptoms over 22 years, including episodic diplopia and bilateral sensory symptoms, demonstrates the challenges of diagnosis. α-GAL genetic analysis should be considered in women with atypical presentations of cerebrovascular disease, and suggestive family history.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Eng CM, Desnick RJ. Molecular basis of Fabry disease: mutations and polymorphisms in the human alpha-galactosidase A gene. Hum Mutat. 1994;3:103.

    Google Scholar 

  2. Mehta A, Ricci R, Widmer U, et al. Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey. Eur J Clin Invest. 2004;34:236–342.

    Google Scholar 

  3. Rolfs A, Böttcher T, Zschiesche M, et al. Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study. Lancet. 2005;366(9499):1794–6.

    Google Scholar 

  4. Gregoire SM, Brown MM, Collas DM, et al. Posterior circulation strokes without systemic involvement as the presenting feature of Fabry disease. J Neurol Neurosurg Psychiatry. 2009;80:1414–6.

    Google Scholar 

  5. Maier EM, Osterrieder S, Whybra C, et al. Disease manifestations and X inactivation in heterozygous females with Fabry disease. Acta Paediatr. 2006;95(Suppl):30–8.

    Google Scholar 

  6. Baehner F, Kapmann C, Whybra C, et al. Enzyme replacement therapy in heterozygous females with Fabry disease: results of a phase IIB study. J Inherit Metab Dis. 2003;26:617–27.

    Google Scholar 

  7. Spada M, Pagliardini S, Yasuda M, et al. High incidence of later-onset Fabry disease revealed by newborn screening. Am J Hum Genet. 2006;79:31–40.

    Google Scholar 

  8. Ginsberg L, Manara R, Valentine AR, et al. Magnetic resonance imaging changes in Fabry disease. Acta Paediatr Suppl. 2006;95(451):57–62.

    Google Scholar 

  9. Reisin RC, Romero C, Marchesoni C, et al. Brain MRI findings in patients with Fabry disease. J Neurol Sci. 2011;305(1–2):41–4.

    Google Scholar 

  10. Baptista MV, Ferreira S, Pinho-E-Melo T, et al. Mutations of the GLA gene in young patients with stroke: the PORTYSTROKE study-screening genetic conditions in Portuguese young stroke patients. Stroke. 2010;41(3):431–6.

    Google Scholar 

  11. Hilz MJ, Kolodny EH, Brys M, et al. Reduced cerebral blood flow velocity and impaired cerebral autoregulation in patients with Fabry disease. J Neurol. 2004;251(5):564–70.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Áine Merwick MB, BMed Sc, MSc, PhD, MRCPI .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag London

About this chapter

Cite this chapter

Merwick, Á., Werring, D.J., Simister, R. (2015). Recurrent Neurological Symptoms Mistaken as Multiple Sclerosis. In: Gill, S., Brown, M., Robertson, F., Losseff, N. (eds) Stroke Medicine. Springer, London. https://doi.org/10.1007/978-1-4471-6705-1_38

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-6705-1_38

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-6704-4

  • Online ISBN: 978-1-4471-6705-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics